News Genfit encounters trial recruitment problem in hunt for NASH... Genfit was among a group of NASH companies publishing updates at the International Liver Congress.
News AbbVie takes aim at Gilead and BMS with 8-week hep C treatme... Trial backs patient-friendly regime in tough to treat strain.
News FDA chief nominee Gottlieb reveals industry links Scott Gottlieb, president Donald Trump’s nomination for FDA commissioner has revealed his close links with pharma.
News Keytruda in new lymphoma use leads latest CHMP decisions MSD keeps pressure on BMS with EU classical Hodgkin lymphoma indication.
News NICE rejects Opdivo in blood cancer, asks for more data Merck's rival Keytruda gets new US indication.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.